Literature DB >> 9756406

HLA-B*27 typing by group-specific hybridization in microtiter plates.

T Wagner1, C Oberkanins, B Weinmayr, W Helmberg, F Kury, G Lanzer.   

Abstract

We have developed and evaluated a test for HLA-B*27 based on PCR and DNA hybridization in microtiter plates. A region within exon 2 of the HLA-B gene is amplified and labeled by PCR and the amplification product is hybridized to a group-specific HLA-B*27 and a generic control oligonucleotide probe in two separate cavities of the plate. Bound sequences are detected using an ELISA-like protocol. The assay has been evaluated on 254 DNA samples routinely received for B27 testing in parallel with serological and SSP-PCR typing. Results were concordant in typing 102 HLA-B27-positive and 152 HLA-B27-negative individuals except for two samples containing HLA-B*73, which stained B27 positive in the microwell test. The new procedure is rapid and simple to perform, and the microwell format is particularly suitable for automation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9756406     DOI: 10.1111/j.1399-0039.1998.tb02281.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  3 in total

1.  [Blood clots in erythrocyte concentrates during transfusion].

Authors:  T Wagner; C Drexler; W Kröll; G Jüngling; G Lanzer; C Gabriel
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

2.  Application of a Simple In-House PCR-SSP Technique for HLA-B* 27 Typing in Spondyloarthritis Patients.

Authors:  Devraj J Parasannanavar; Anjali Rajadhyaksha; Kanjaksha Ghosh
Journal:  Arthritis       Date:  2013-12-19

3.  Human HLA-B27 typing using the BD™ HLA-B27 kit on the BD FACSVia™ system: A multicenter study.

Authors:  Yang Zeng; Alan Hiti; Sherry Moranville; Gloria Vicent; Sylvia Chavira; Monika de Arruda Indig; Sharon Graminske; Amanda Boerner; Anna Schmidt; Farzad Oreizy; Angela Chen; Maryam Saleminik; Fred Mosqueda; Anna Lin; Kevin Judge
Journal:  Cytometry B Clin Cytom       Date:  2018-04-11       Impact factor: 3.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.